Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Erol

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|June 1, 2019
Novel Approaches in Ovarian Cancer Research against Heterogeneity, Late Diagnosis, Drug Resistance, and Transcoelomic MetastasesAnna Erol, Magdalena Niemira, Adam Jacek Krętowski
Computational and Structural Biotechnology Journal|May 13, 2024
Challenges and opportunities in processing NanoString nCounter dataJarosław Chilimoniuk, Anna Erol, Stefan Rödiger, et al.
Plants (Basel, Switzerland)|February 9, 2020
Physiological Response of <i>Miscanthus x giganteus</i> to Plant Growth Regulators in Nutritionally Poor SoilHana Malinská, Valentina Pidlisnyuk, Diana Nebeská, et al.
Molecular Biology Reports|July 15, 2026
Genetic diversity within Miscanthus × giganteus: Evidence from morphological traits and ITS rDNA in European accessionsHana Auer Malinská, Diana Polanská Nebeská, Michaela Kocholatá, et al.
Scientific Reports|August 23, 2023
Identification and subsequent validation of transcriptomic signature associated with metabolic status in endometrial cancerIwona Sidorkiewicz, Maciej Jóźwik, Angelika Buczyńska, et al.
Journal of Clinical Medicine|July 16, 2020
Circulating miRNAs as a Predictive Biomarker of the Progression from Prediabetes to Diabetes: Outcomes of a 5-Year Prospective Observational StudyIwona Sidorkiewicz, Magdalena Niemira, Katarzyna Maliszewska, et al.
Scientific Reports|November 7, 2023
Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancerMagdalena Niemira, Anna Erol, Agnieszka Bielska, et al.
Frontiers in Molecular Biosciences|March 8, 2024
Circulating serum miR-362-3p and miR-6721-5p as potential biomarkers for classification patients with adult-type diffuse gliomaMagdalena Niemira, Agnieszka Bielska, Karolina Chwialkowska, et al.
Molecular Oncology|August 8, 2025
Adenosine-to-inosine editing of miR-200b-3p is associated with the progression of high-grade serous ovarian cancerMagdalena Niemira, Anna Skwarska, Karolina Chwialkowska, et al.
Computers in Biology and Medicine|June 5, 2025
Repurposing of PI3K inhibitors for high-grade serous ovarian cancer: A novel competing endogenous network analysis-based approachAnna Erol, Karolina Chwialkowska, Anna Zeller, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|June 1, 2019
Novel Approaches in Ovarian Cancer Research against Heterogeneity, Late Diagnosis, Drug Resistance, and Transcoelomic MetastasesAnna Erol, Magdalena Niemira, Adam Jacek Krętowski
Computational and Structural Biotechnology Journal|May 13, 2024
Challenges and opportunities in processing NanoString nCounter dataJarosław Chilimoniuk, Anna Erol, Stefan Rödiger, et al.
Plants (Basel, Switzerland)|February 9, 2020
Physiological Response of <i>Miscanthus x giganteus</i> to Plant Growth Regulators in Nutritionally Poor SoilHana Malinská, Valentina Pidlisnyuk, Diana Nebeská, et al.
Molecular Biology Reports|July 15, 2026
Genetic diversity within Miscanthus × giganteus: Evidence from morphological traits and ITS rDNA in European accessionsHana Auer Malinská, Diana Polanská Nebeská, Michaela Kocholatá, et al.
Scientific Reports|August 23, 2023
Identification and subsequent validation of transcriptomic signature associated with metabolic status in endometrial cancerIwona Sidorkiewicz, Maciej Jóźwik, Angelika Buczyńska, et al.
Journal of Clinical Medicine|July 16, 2020
Circulating miRNAs as a Predictive Biomarker of the Progression from Prediabetes to Diabetes: Outcomes of a 5-Year Prospective Observational StudyIwona Sidorkiewicz, Magdalena Niemira, Katarzyna Maliszewska, et al.
Scientific Reports|November 7, 2023
Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancerMagdalena Niemira, Anna Erol, Agnieszka Bielska, et al.
Frontiers in Molecular Biosciences|March 8, 2024
Circulating serum miR-362-3p and miR-6721-5p as potential biomarkers for classification patients with adult-type diffuse gliomaMagdalena Niemira, Agnieszka Bielska, Karolina Chwialkowska, et al.
Molecular Oncology|August 8, 2025
Adenosine-to-inosine editing of miR-200b-3p is associated with the progression of high-grade serous ovarian cancerMagdalena Niemira, Anna Skwarska, Karolina Chwialkowska, et al.
Computers in Biology and Medicine|June 5, 2025
Repurposing of PI3K inhibitors for high-grade serous ovarian cancer: A novel competing endogenous network analysis-based approachAnna Erol, Karolina Chwialkowska, Anna Zeller, et al.
Pageof 1